MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy.

Abstract

Loss of PTEN and activation of phosphoinositide 3-kinase are commonly observed in advanced prostate cancer. Inhibition of mammalian target of rapamycin (mTOR), a downstream target of phosphoinositide 3-kinase signaling, results in cell cycle arrest and apoptosis in multiple in vitro and in vivo models of prostate cancer. However, single-agent use of mTOR inhibition has limited clinical success, and the identification of molecular events mitigating tumor response to mTOR inhibition remains a critical question. Here, using genetically engineered human prostate epithelial cells (PrEC), we show that MYC, a frequent target of genetic gain in prostate cancers, abrogates sensitivity to rapamycin by decreasing rapamycin-induced cytostasis and autophagy. Analysis of MYC and the mTOR pathway in human prostate tumors and PrEC showed selective increased expression of eukaryotic initiation factor 4E-binding protein 1 (4EBP1) with gain in MYC copy number or forced MYC expression, respectively. We have also found that MYC binds to regulatory regions of the 4EBP1 gene. Suppression of 4EBP1 expression resulted in resensitization of MYC-expressing PrEC to rapamycin and increased autophagy. Taken together, our findings suggest that MYC expression abrogates sensitivity to rapamycin through increased expression of 4EBP1 and reduced autophagy.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1158/0008-5472.CAN-09-0910

Publication Info

Balakumaran, Bala S, Alessandro Porrello, David S Hsu, Wayne Glover, Adam Foye, Janet Y Leung, Beth A Sullivan, William C Hahn, et al. (2009). MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy. Cancer Res, 69(19). pp. 7803–7810. 10.1158/0008-5472.CAN-09-0910 Retrieved from https://hdl.handle.net/10161/4170.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Sullivan

Beth Ann Sullivan

James B. Duke Distinguished Professor

Research in the Sullivan Lab is focused on chromosome organization, with a specific emphasis on the genomics and epigenetics of the chromosomal locus called the centromere. The centromere is a specialized chromosomal site involved in chromosome architecture and movement, and when defective, is linked to cancer, birth defects, and infertility. The lab has described a unique type of chromatin (CEN chromatin) that forms exclusively at the centromere by replacement of core histone H3 by the centromeric histone variant CENP-A. Their studies also explore the composition of CEN chromatin and its relationship to the underlying highly repetitive alpha satellite DNA at the centromere. The Sullivan lab also discovered that genomic variation within alpha satellite DNA affects where the centromere is built and how well it functions. The Sullivan lab was part of the Telomere-to-Telomere T2T Consortium that used ultra long read sequencing and optical mapping to completely assemble each human chromosome, including through millions of basepairs of alpha satellite DNA at each centromere. Dr. Sullivan's group also builds human artificial chromosomes (HACs), using them as tools to test components required for a viable, transmissible chromosome and to study centromeric transcription and chromosome stability. The lab also studies formation and fate of chromosome abnormalities associated with birth defects, reproductive abnormalities, and cancer. Specifically, they study chromosomal abnormalities with two centromeres, called dicentric chromosomes. Originally described by Nobelist Barbara McClintock in the 1930s, dicentrics in most organisms are considered inherently unstable chromosomes because they trigger genome instability. However, dicentric chromosomes in humans are very stable and are often transmitted through multiple generations of a family. Using several approaches to experimentally reproduce dicentric chromosomes in human cells, the lab explores mechanisms of dicentric formation and their long-term fate.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.